Rett Syndrome Update: Evolving Management Strategies – Part 2 (CME/CE Webcast)
Activity Description and Purpose
This educational activity will focus on recognition of Rett syndrome, with a review of the latest guidelines and best practices to implementing the guidelines through a case study. Additionally, a review of recent clinical trial data of newly approved and emerging disorder-specific therapies for Rett syndrome will be provided. The desired results of this activity are to increase the knowledge and competence of neurologists who treat patients with Rett syndrome and nurse practitioners and physician assistants who may work with neurologists who treat/encounter patients with Rett syndrome.
This educational activity is intended for pediatric neurologists, neurologists, nurse practitioners, physician assistants, and other clinicians who treat Rett syndrome.
After completing this activity, participants will be better able to:
- Summarize the latest guidelines available for Rett syndrome
- Implement guideline-concordant management plans for Rett syndrome that use an integrated multidisciplinary approach
- Review recent clinical trial data for new and emerging disorder-specific therapies for Rett syndrome
|Jeffrey L. Neul, MD, PhD|
Annette Schaffer Eskind Chair and Director
Vanderbilt Kennedy Center
Professor of Pediatrics
Division of Neurology, Pharmacology, and Special Education
Vanderbilt University Medical Center
Alan K. Percy, MD
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Jeffrey L. Neul, MD, PhD, is a consultant for F. Hoffmann-La Roche Ltd, Jazz Pharmaceuticals Inc, Myrtelle, and Taysha GTx; and is an advisory board member of Alcyone Therapeutics and Ovid Therapeutics.
Alan K. Percy, MD, is a consultant for ACADIA Pharmaceuticals Inc; and is an advisory board member of Taysha GTx.
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.
Other MedEdicus and Amedco planners, managers, and writers have no relevant commercial relationships to disclose.
Learners must view the webcast and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be viewed in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
ACCME Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Credit Designation Statement
MedEdicus LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Interprofessional Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 0.5 ANCC contact hour.
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from ACADIA Pharmaceuticals Inc.
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at firstname.lastname@example.org.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or ACADIA Pharmaceuticals Inc.
©2023 MedEdicus LLC. 286.1b
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation